| 05/15/2026 10:57 AM | EVENTIDE ASSET MANAGEMENT, LLC (1442891) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G | |
| 05/15/2026 7:03 AM | Ovid Therapeutics (1636651) Subject Sirenia Capital Management LP (2115022) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 5:31 AM | BALYASNY ASSET MANAGEMENT L.P. (1218710) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G | |
| 05/14/2026 3:17 PM | Affinity Asset Advisors, LLC (1773195) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G/A | |
| 05/12/2026 6:04 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2026 6:06 AM | Ovid Therapeutics (1636651) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/27/2026 4:11 PM | Ovid Therapeutics (1636651) Filer | Form DEF 14A | |
| 04/27/2026 4:12 PM | Ovid Therapeutics (1636651) Filer | Form DEFA14A | |
| 04/27/2026 4:12 PM | Ovid Therapeutics (1636651) Filer | Form ARS | |
| 04/27/2026 4:01 PM | Ovid Therapeutics (1636651) Filer | Form 424B3 | |
| 04/26/2026 11:15 PM | Ovid Therapeutics (1636651) Filer | Form EFFECT | |
Get the Latest News and Ratings for OVID and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/21/2026 3:31 PM | Ovid Therapeutics (1636651) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 04/20/2026 7:16 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/09/2026 4:15 PM | Fitzgerald Kevin Joseph (1886431) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 4:15 PM | Friedman Bart (1368324) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 4:15 PM | Ovid Therapeutics (1636651) Issuer PAPADOPOULOS STELIOS (1202098) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 8:18 PM | LEVIN JEREMY M (1256153) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 3:49 PM | Ovid Therapeutics (1636651) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/18/2026 3:25 PM | Ovid Therapeutics (1636651) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/02/2026 3:30 PM | Ovid Therapeutics (1636651) Issuer Rona Jeffrey A (1311404) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | Bernstein Karen (1654055) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | DUNCAN BARBARA GAYLE (1353128) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | Friedman Bart (1368324) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | LEVIN JEREMY M (1256153) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | Fitzgerald Kevin Joseph (1886431) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | Ovid Therapeutics (1636651) Issuer PAPADOPOULOS STELIOS (1202098) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:30 PM | ALEXANDER MARGARET A. (2036798) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 7:17 PM | ADAR1 Capital Management, LLC (1940272) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G | |
| 01/29/2026 6:57 PM | Affinity Asset Advisors, LLC (1773195) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G/A | |
| 01/08/2026 10:56 AM | FEDERATED HERMES, INC. (1056288) Filed by FEDERATED HERMES, INC. (1056288) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G | |
| 01/05/2026 4:55 PM | ALEXANDER MARGARET A. (2036798) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 11:15 PM | Ovid Therapeutics (1636651) Filer | Form EFFECT | |
| 12/22/2025 3:28 PM | Ovid Therapeutics (1636651) Filer | Form 424B3 | |
| 12/18/2025 5:07 PM | Ovid Therapeutics (1636651) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13G | |
| 12/18/2025 3:15 PM | LEVIN JEREMY M (1256153) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 3:06 PM | Affinity Asset Advisors, LLC (1773195) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G | |
| 12/18/2025 7:39 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/15/2025 4:26 PM | Ovid Therapeutics (1636651) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 12/11/2025 12:58 PM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/09/2025 8:02 PM | Ovid Therapeutics (1636651) Subject TAKEDA PHARMACEUTICAL CO LTD (1395064) Filed by | Form SCHEDULE 13G/A | |
| 12/09/2025 8:19 PM | Ovid Therapeutics (1636651) Issuer TAKEDA PHARMACEUTICAL CO LTD (1395064) Reporting Takeda Pharmaceuticals U.S.A., Inc. (1716229) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history.
But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing |
| 12/08/2025 10:45 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G | |
| 11/12/2025 6:02 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 6:04 AM | Ovid Therapeutics (1636651) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/07/2025 5:06 AM | Ovid Therapeutics (1636651) Filer | Form DEF 14A | |
| 10/27/2025 8:39 PM | Ovid Therapeutics (1636651) Filer | Form PRE 14A | |
| 10/27/2025 4:27 PM | Ovid Therapeutics (1636651) Filer | Form PREM14A | |
| 10/03/2025 4:09 PM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/16/2025 7:00 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 7:02 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 7:03 AM | Ovid Therapeutics (1636651) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/21/2025 5:36 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G/A | |
| 07/17/2025 7:12 PM | BlackRock, Inc. (2012383) Filed by Ovid Therapeutics (1636651) Subject | Form SCHEDULE 13G/A | |
| 07/10/2025 3:29 PM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2025 7:22 AM | Ovid Therapeutics (1636651) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2025 3:45 PM | Bernstein Karen (1654055) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 3:45 PM | Duncan Barbara Gayle (1353128) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 3:45 PM | Friedman Bart (1368324) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 3:45 PM | Fitzgerald Kevin Joseph (1886431) Reporting Ovid Therapeutics (1636651) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2025 7:04 AM | Ovid Therapeutics (1636651) Filer | Form DEF 14A | |
| 05/22/2025 7:05 AM | Ovid Therapeutics (1636651) Filer | Form DEFA14A | |
| 05/22/2025 7:05 AM | Ovid Therapeutics (1636651) Filer | Form ARS | |